In this episode of #AskDrDurie, Dr. Brian Durie, IMF Chairman and 
Co-Founder, talks about the Black Swan Research Initiative(R)'s various clinical trials and how eligible patients can get more information and potentially participate in them.

Dr. Brian G.M. Durie is the Chairman of the Board of Directors of the International Myeloma Foundation. He began studying multiple myeloma over 30 years ago, and is recognized around the world as one of the top myeloma doctors.

Previous Post
#AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?
Next Post
#AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.